Caplin Point Laboratories LimitedNSE: CAPLIPOINT

Press Release Apr 19 2021

Apr 19, 2021 at 5:06 PM UTC

Caplin Point Laboratories Limited has informed the Exchange regarding a press release dated April 19, 2021, titled "Caplin Steriles Gets USFDA Approval for Milrinonelactate Injection".

View Attachment